tiprankstipranks
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
US Market
AARD
Aardvark Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see AARD full AI Analyst Report?

Aardvark Therapeutics, Inc. (AARD) Financial Statements

156 Followers

Aardvark Therapeutics, Inc. Financial Overview

Aardvark Therapeutics, Inc.'s market cap is currently $117.59M. The company's EPS TTM is $-0.81; its P/E ratio is -4.47; Aardvark Therapeutics, Inc. is scheduled to report earnings on April 6, 2026, and the estimated EPS forecast is $-0.88. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -36.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -62.73M$ -22.79M$ -7.42M$ -11.36M
EBITDA$ -62.73M$ -22.65M$ -6.65M$ -9.76M
Net Income$ -57.59M$ -20.59M$ -7.21M$ -13.56M
Balance Sheet
Cash & Short-Term Investments$ 110.03M$ 73.66M$ 9.99M$ 16.11M
Total Assets$ 117.18M$ 77.51M$ 10.54M$ 16.76M
Total Debt$ 441.00K$ 779.00K$ 162.00K$ 262.00K
Net Debt$ -46.61M$ -60.86M$ -9.57M$ -15.30M
Total Liabilities$ 10.55M$ 132.15M$ 45.34M$ 44.68M
Stockholders' Equity$ 106.63M$ -54.64M$ -34.80M$ -27.92M
Cash Flow
Free Cash Flow$ -54.27M$ -18.20M$ -5.82M$ -10.54M
Operating Cash Flow$ -54.17M$ -18.09M$ -5.82M$ -10.54M
Investing Cash Flow$ -49.67M$ -12.00M$ 0.00$ -1.00M
Financing Cash Flow$ 89.25M$ 81.99M$ 0.00$ 225.00K
Currency in USD

Aardvark Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Aardvark Therapeutics, Inc. Debt to Assets

Balance Sheet >

Aardvark Therapeutics, Inc. Cash Flow

Cash Flow >

Aardvark Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >